Delivery Order SPE2DR25D2101-SPE2DR26F45LC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,563.08 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,278.50 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe form. This contract, designated as a firm fixed price delivery order with no set-aside, was awarded on September 19, 2025, with an ultimate completion date of September 22, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe form, valued at $1,569.21, with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $17,246.08 and a firm fixed price structure. This non-competitive delivery order is set to conclude on May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,761.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe form, with a completion deadline of November 4, 2025. The contract, issued on November 3, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Twinrix vaccine in syringe format, with a contract ceiling value of $2,140.77. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order is scheduled for completion by September 24, 2025, and represents a small-value transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Twinrix vaccine in syringe form, with a contract ceiling value of $4,948.52. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $1,932.13. This competitively awarded, firm fixed-price delivery order is classified as a child contract and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The award carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $13,811.09 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Twinrix vaccine in syringe format. This is a firm fixed-price contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of October 21, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, fulfills this order as a...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F45LCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Twinrix vaccine in syringe form, with a ceiling value of $4,735.42 and an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle that runs through December 2026 and enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems through its DLA contracts. The company's federal contract portfolio demonstrates significant capability in delivering diverse pharmaceutical products, including vaccines, specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This Twinrix vaccine delivery order reflects the company's ongoing role in supporting Defense Health Agency medical supply requirements through competitively awarded, firm fixed-price transactions under its expansive prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 11/3/25 |